The pre-specified secondary outcomes were (1) all cause-mortality and (2) incidence of a cardiovascular composite event outcome that included: first occurrence of acute myocardial infarction, cardiac arrest or ventricular fibrillation, acute stroke, or coronary revascularization, as previously described and validated using validated International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) and 10th Revision, Clinical Modification (ICD-10-CM) and procedure codes 52,53,54
"Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor"
Applied Nutrition launches L-Carnitine sports drink Applied Nutrition, a UK based sports nutrition company has announced the launch of its new L-Carnitine sports drink
All peptide information is derived from published scientific literature examining individual peptides
This is a detailed systematic review of the polymorphisms of ABCB1 and cytochrome P450 associated with poor prognosis of treatment of cancer
Stress management: Practice stress reduction techniques, as stress can exacerbate hair loss